"When a company is issued a patent, it can sell the item covered by the patent on the open market without having to worry about competitors coming in and snatching up a piece of the action. But the problem with patents is that they only have a limited life, and when they run out, they can significantly impact a company's bottom line. This is a particular problem in the pharmaceutical industry, where drug companies rely on patents to sell the products they work so hard to develop. That's why drug companies are often subjected to what's known as a patent cliff. A patent cliff is what happens when a company's revenue starts plunging, or falling off a cliff, because an established product's patent reaches its expiration date and competitors can then start selling that product. While the term technically applies to any industry, it most frequently comes into play when talking about pharmaceutical companies."
The Ebook version of my Bloomsbury book "Ethics, Information, and Technology" will be published on December 11, 2025 and the Hardback and Paperback versions will be available on January 8, 2026. The book includes chapters on IP, OM, AI, and other emerging technologies. Preorders are available via Amazon and this Bloomsbury webpage: https://www.bloomsbury.com/us/ethics-information-and-technology-9781440856662/
Showing posts with label exclusivity. Show all posts
Showing posts with label exclusivity. Show all posts
Thursday, July 7, 2016
What Is a Patent Cliff?; Fool.com via Fox Business, 7/6/16
Motley Fool Staff, Fool.com via Fox Business; What Is a Patent Cliff? :
Subscribe to:
Posts (Atom)